April 29th, 2013
Selections from Richard Lehman’s Literature Review: April 29th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the association of perioperative beta-blockade with mortality and CV morbidity following major noncardiac surgery, intestinal microbial metabolism of phosphatidylcholine and CV risk, and more.
April 20th, 2011
New WHI Analysis Links Calcium Supplements to CV Risk
Larry Husten, PHD
A new analysis may renew concerns that the combination of calcium supplements and vitamin D might increase cardiovascular risk. The link has been proposed before, but the Women’s Health Initiative (WHI) found no additional risk. Now, however, in an article appearing in BMJ, Mark Bolland and colleagues point out that more than half the 36,000 […]
July 31st, 2010
Calcium Supplements Linked to Increase in CV Events
Larry Husten, PHD
People who take calcium supplements may be at increased risk for cardiovascular events, according to a meta-analysis published in the British Medical Journal. Mark Bolland and colleagues analyzed data from 15 randomized, placebo-controlled trials and found a significant increase in the risk of MI in subjects who received calcium supplements. The authors concluded that “although […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?